Skip to content

Drug interactions

Buprenorphine subdermal implant + Oxymorphone

Severity: Major

Buprenorphine subdermal implant and Oxymorphone: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Buprenorphine from an implant occupies mu receptors continuously and can blunt the effect of a full agonist like oxymorphone. It may also precipitate withdrawal in dependent patients, and additive sedation is possible.

What this interaction means in plain words

Buprenorphine subdermal implant and Oxymorphone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Evidence level: Moderate

Why it happens

Partial agonist receptor competition with a full agonist plus additive CNS depression.

What to do

Avoid combining unless essential; monitor for reduced analgesia, withdrawal and respiratory depression. Seek specialist input for pain management in implant patients.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Oxymorphone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Buprenorphine subdermal implant with Oxymorphone?

MediHelp rates the interaction as major. Buprenorphine subdermal implant and Oxymorphone can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Buprenorphine from an implant occupies mu receptors continuously and can blunt the effect of a full agonist like oxymorphone. It may also precipitate withdrawal in dependent patients, and additive sedation is possible.

How serious is the interaction between Buprenorphine subdermal implant and Oxymorphone?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining unless essential; monitor for reduced analgesia, withdrawal and respiratory depression. Seek specialist input for pain management in implant patients.

What other medicines interact with Oxymorphone?

MediHelp also lists interactions of Oxymorphone with, for example, Alvimopan, Ethanol, Isocarboxazid. The full list is on the Oxymorphone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in